Back
Lantern Pharma Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
32
LTRN
Lantern Pharma
Last Price:
4.05
Seasonality Move:
-0.83%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
40.33
Seasonality Move:
-0.9%
Sell
32
Lantern Pharma (LTRN)
is a Sell
Is Lantern Pharma a Buy, Sell or Hold?
- The current Lantern Pharma [LTRN] share price is $4.02. The Score for LTRN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- LTRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LTRN Stock Price Chart
What is Lantern Pharma's stock price today?
-
The Lantern Pharma share price today is $4.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LTRN is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
LTRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.54 | Sell |
Relative Strength Index (14 RSI): | 27.41 | Sell |
Chaikin Money Flow: | 12008 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.8 - 6.34) | Sell |
Bollinger Bands (100): | (4.39 - 7.69) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.7 | Sell |
Relative Strength Index (14 RSI): | 46.74 | Sell |
Chaikin Money Flow: | 84619 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.82 - 42.02) | Sell |
Bollinger Bands (100): | (40.86 - 48.8) | Sell |
LTRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.61 | Sell |
20-day SMA: | 5.41 | Sell |
50-day SMA: | 5.74 | Sell |
200-day SMA: | 4.88 | Sell |
8-day EMA: | 4.53 | Sell |
20-day EMA: | 5.15 | Sell |
50-day EMA: | 5.7 | Sell |
200-day EMA: | 5.39 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.53 | Buy |
20-day SMA: | 40.36 | Sell |
50-day SMA: | 41.57 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.71 | Buy |
20-day EMA: | 40.38 | Sell |
50-day EMA: | 41.84 | Sell |
200-day EMA: | 43.38 | Sell |
Lantern Pharma Earnings Growth & LTRN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and an increase next year of $0.24 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Lantern Pharma Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |